Overview
Kexin Ai practices practicing medicine in Guangzhou, China.
Her clinical expertise encompasses Adult T-Cell Leukemia, Leukemia, and Chronic Myelogenous Leukemia (CML).
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kexin Ai
Is Kexin Ai a top-rated expert for Adult T-Cell Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Kexin Ai is classified as an Experienced expert for Adult T-Cell Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kexin Ai participate in research or clinical trials?
Yes. Kexin Ai has published 8 articles and abstracts on conditions like Adult T-Cell Leukemia. You can view a list of Kexin Ai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult T-Cell LeukemiaMs. Ai isExperienced. Learn about Adult T-Cell Leukemia.
- Chronic Myelogenous Leukemia (CML)
- LeukemiaMs. Ai isExperienced. Learn about Leukemia.